Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Systematic Review

Published on 07 Apr 2025

A bibliometric and visual analysis based on immune checkpoint inhibitors for hepatocellular carcinoma: 2014 – 2024

in Pharmacology of Anti-Cancer Drugs

Gao-Min Liu
Rui Guo
Ji-Wei Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520055

278 views

Original Research

Published on 04 Apr 2025

MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study

in Pharmacology of Anti-Cancer Drugs

Rui Bergantim
Sara Peixoto da Silva
Vanessa Pinto
Joana M. Pereira
Diana Sousa
Fernanda Trigo
Rune Matthiesen
José E. Guimarães
M. Helena Vasconcelos

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1465814

402 views

Original Research

Published on 04 Apr 2025

Development and validation of hierarchical signature for precision individualized therapy based on the landscape associated with necroptosis in clear cell renal cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Gao-Sheng Yao
Jun-Shang Dai
Liang-Min Fu
Juan Lin
Zhi-Ping Tan
Lei Dai
Wei Chen
Jun-Hang Luo
Jin-Huan Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1470145

301 views

Original Research

Published on 03 Apr 2025

Norcantharidin inhibits TOP2A expression via H3K27me3 mediated epigenetic regulation to alleviate the progression of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Ruibing Wu
Hengye Yuan
Yuehua Wang
Xianggang Gou
Wanhua Hou
Zhongzheng Zhou
Xinran Wang
Xiuling Deng
Changshan Wang
Haisheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1541298

413 views

Original Research

Published on 03 Apr 2025

Synergistic anticancer potential of biogenic nanoparticles and cryptomeridiol from Sphaeranthus indicus: targeting gastric cancer through apoptosis and cell cycle arrest

in Pharmacology of Anti-Cancer Drugs

Pan Zhao
Jigang Wang
Chang Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565308

482 views

Original Research

Published on 03 Apr 2025

From COPD to cancer: indacaterol’s unexpected role in combating NSCLC

in Pharmacology of Anti-Cancer Drugs

Chenghao Liu
Jiaqi Huang
Pengjie Cai
Min Jiang
Honglei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579126

317 views

Original Research

Published on 02 Apr 2025

Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation

in Pharmacology of Anti-Cancer Drugs

Ni Zhang
Xinchen Tian
Fen Liu
Xiaohan Jin
Jiaqi Zhang
Lingli Hao
Shulong Jiang
Qingbin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514997

556 views

Original Research

Published on 02 Apr 2025

Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Yaqian Tan
Hui Xia
Qi Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540619

450 views

Original Research

Published on 02 Apr 2025

Discovery of benzethonium chloride as a potent STAT3 inhibitor for the treatment of HNSCC

in Pharmacology of Anti-Cancer Drugs

Yuefeng Han
Shumin Li
Deshang Chen
Mingjie Zhang
Guoying Han
QianQian Xu
Xianming Ge
Mengli Wang
Yan Pan
Sien Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569570

500 views

Original Research

Published on 02 Apr 2025

Therapeutic potential and mechanistic insights of silibinin targeting cancer-associated fibroblasts in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Shenglan He
Jianmei Ji
Kaisi Zhu
Youlan Chen
Xiaowen Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1527871

445 views

Original Research

Published on 01 Apr 2025

New prognostic features and personalized treatment strategies of mitochondrial related genes in colorectal cancer patients

in Pharmacology of Anti-Cancer Drugs

Qizheng Xu
Zhiwen Wang
Shan-Tao Huang
Jia-Yu Shi
Yan Zhu
Han-Qing Pang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540767

307 views

Original Research

Published on 01 Apr 2025

Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data

in Pharmacology of Anti-Cancer Drugs

Junchao Wu
Wentian Wu
Jiaxuan Qin
Ziqi Chen
Rongfang Zhong
Peng Guo
Song Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1573611

512 views

Systematic Review

Published on 01 Apr 2025

Efficacy and safety of tirabrutinib monotherapy in relapsed or refractory B-cell lymphomas/leukemia: a meta-analysis

in Pharmacology of Anti-Cancer Drugs

Jingfei Wang
Hai-en Cheng
Yanhua Sun
Zhenfeng Li
Yunke Zang
Yuying Zhao
Guimao Yang
Zhijun Liu
Yaqi Sun
Yanli Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559056

872 views

Case Report

Published on 01 Apr 2025

Case Report: Second-line favourable effect of pembrolizumab plus chemotherapy in a patient with metastatic hepatoid adenocarcinoma of the stomach

in Pharmacology of Anti-Cancer Drugs

Yao Tang
Xiaofen Li
Yu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1387661

332 views

Systematic Review

Accepted on 31 Mar 2025

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

in Pharmacology of Anti-Cancer Drugs

Dandan Gu
Shaoyang Huang
Kai Zhao
Xiaohong Zhang
Jinjing Zhang
Wei Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564561

Review

Published on 28 Mar 2025

The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression

in Pharmacology of Anti-Cancer Drugs

Yongsheng Zhang
Yanjiao Xu
Yanping Zhang
Shoushi Wang
Mingqiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559408

394 views